National Cancer Institute, Naples clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
3 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 1 with a minor change only.
- Notable: Application of da Vinci SP for Endometrial Cancer Surgical Staging Primary completion pushed from Jun 2026 to Jun 2027
- Minor: Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas Primary completion date changed from estimate of Nov 19, 2025 to Apr 21, 2026
- Notable: FOCUS-AFM · Using Artificial Intelligence to Guide Fluid Therapy During Major Cancer Surgery: A Randomized Controlled Trial Primary completion pushed from Feb 2027 to Dec 2027
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Early Phase 1 | 1 | |
| Phase 1 | 1 | |
| Phase 2 | 11 | |
| Phase 3 | 2 |
Not charted: 21 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 13
Colorectal Cancer (8) · Endometrial Cancer (4) · Breast Cancer (3) · Ovarian Cancer (3) · Head & Neck Cancer (2) · Liver Cancer (2) · Cervical Cancer (1) · Cholangiocarcinoma (1) · Esophageal Cancer (1) · Multiple Myeloma (1)
Get alerts when National Cancer Institute, Naples's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.